Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness

This observational study will seek to describe the uses and safety and efficacy outcomes of treprostinil in clinical practice in patients with persistent pulmonary hypertension (PPHN).

Participants needed: 60
Trial details
Age: Up to 44Biological sex: AllType: ObservationalSponsor: Ferrer Internacional S.A.Updated: Sep 3, 2025Locations: 4
Eligibility criteria

Newborn infants who received at least one dose of IV or SC treprostinil as per c... [+4]

None.

Status: Available

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

This is an Expanded Access Program (EAP) for eligible participants with Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) designed to provide access to Inhaled Treprostinil. Availability will depend on territory elegibility.

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Ferrer Internacional S.A.Updated: Oct 10, 2022
Eligibility criteria

Patient consent [+2]

Diagnosis of PAH or PH for reasons other than Group 3 PH-ILD [+2]